Figure 9
The common pattern template of required activation functions of input factors associated with complete tumour regression. (A) Unimodal intensity of chemotherapy (temozolomide). (B) Bimodal intensity of leucocyte immunotherapy (cytotoxic lymphocyte). (C) Uniform truncated intensity of cytokine immunotherapy (interleukin-2). (D) Saturating intensity of the tissue protective entities: natural killer cells and circulating lymphocytes.